SEP Analytical (Shanghai) Co. Ltd. (301228) — Capital Reinvestment Ratio

Latest as of December 2025: 1.47x

SEP Analytical (Shanghai) Co. Ltd. (301228) has a Capital Reinvestment Ratio of 1.47x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥39.86 Million) in capital expenditures (CN¥58.71 Million). Check how tangible is SEP Analytical (Shanghai) Co. Ltd.'s equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.47x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥39.86 Million
CNY

Capital Expenditures

CN¥58.71 Million
CNY

Data as of

Dec 2025
Most recent filing

SEP Analytical (Shanghai) Co. Ltd. Capital Reinvestment Ratio (2019–2025)

This chart tracks SEP Analytical (Shanghai) Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see SEP Analytical (Shanghai) Co. Ltd. operating cash flow efficiency.

Annual Capital Reinvestment Ratio for SEP Analytical (Shanghai) Co. Ltd. (2019–2025)

Year-by-year Capital Reinvestment Ratio for SEP Analytical (Shanghai) Co. Ltd. from 2019 to 2025. See cash generation quality of SEP Analytical (Shanghai) Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 1.47x CN¥39.86 Million CN¥58.71 Million ▲ +122.7%
2024 0.66x CN¥24.35 Million CN¥16.11 Million ▼ -90.2%
2022 6.73x CN¥7.82 Million CN¥52.64 Million ▲ +1929.5%
2021 0.33x CN¥86.53 Million CN¥28.70 Million ▼ -82.7%
2020 1.92x CN¥38.75 Million CN¥74.34 Million ▼ -41.2%
2019 3.26x CN¥22.49 Million CN¥73.37 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow